MARKET RADAR
SENSEX     NIFTY      Refresh
YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > News - Ranbaxy Laboratories
Ranbaxy Laboratories
BSE: 500359|NSE: RANBAXY|ISIN: INE015A01028|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
May 22, 13:27
431.50
-4.85 (-1.11%)
VOLUME 102,834
LIVE
NSE
May 22, 13:27
431.10
-5.25 (-1.2%)
VOLUME 762,413
Earnings News on Ranbaxy Laboratories
Select Year: 2013 |  2012 |  2011 | 2010 | 2009 | 2008 | 2007 | 2000-2006
Indian pharmas gain on N America boost: Q4 earnings review 

8.49 pm | 09 May 2013 |  Source: CNBC-TV18

CNBC-TV18’s Archana Shukla reports that the pharma sector’s fortunes in the January-March quarter were dictated by the US market while the sector'...

Why SBICap remains bullish on Ranbaxy despite weak Q1 nos 

5.43 pm | 08 May 2013 |  Source: CNBC-TV18

SBI Cap Securities’ Vivek Kumar continues to be bullish on Ranbaxy Laboratories despite its poor first quarter earnings; as against other brokerage ...

Ranbaxy misses estimates; Q1 net sinks 90% 

3.16 pm | 08 May 2013 |  Source: Moneycontrol.com

Ranbaxy's first quarter consolidated net profit plunged 90 percent to Rs 126 crore, while net sales fell 34 percent to Rs 2,439.8 crore in Jan-March. ...

Ranbaxy Q1 net profit plunges, lags estimates 

2.13 pm | 08 May 2013 |  Source: Reuters

Ranbaxy Laboratories, India's largest drugmaker by sales, reported a 90 percent drop in first quarter net profit compared to the same year-ago period,...

Ranbaxy Q1 profit likely at Rs 173cr; revenue seen down 31% 

12.21 pm | 08 May 2013 |  Source: CNBC-TV18

Ranbaxy's first quarter net profit is seen at Rs 173 crore, compared with a Rs 1,246 crore profit in the year ago quarter, according to a CNBC-TV18 po...

IIFL gung-ho on pharma, expects Sun to beat Q4 estimates 

6.33 pm | 18 Apr 2013 |  Source: CNBC-TV18

Bino Pathiparampil of IIFL, says that stock like Sun Pharma has been beating estimates for last eight quarters and the same performance is likely to c...

Pharma cos likely to post 21% EBITDA growth in Q4: MOST 

1.30 pm | 16 Apr 2013 |  Source: Moneycontrol.com

Motilal Oswal has come with its March`13 quarterly earning estimates for healthcare sector. The research firm expects a top line growth of 17.4% YoY a...

Ranbaxy slips further as Q4 results disappoint street 

10.50 am | 27 Feb 2013 |  Source: Moneycontrol.com

Ranbaxy shares tumbled 4 percent on Wednesday morning, extending Tuesday's losses on a surprise fourth quarter loss on the back of falling sales and c...

Ranbaxy Q4 net loss at Rs 492 cr, sales fall 29% 

4.29 pm | 26 Feb 2013 |  Source: Moneycontrol.com

Pharma major Ranbaxy reported a fourth quarter consolidated net loss of Rs 492 crore, lower than the Rs 2,983 crore loss it reported a year ago. ...

1
Quick Links for Ranbaxy Laboratories
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.